Keyword Search Results for "biomarker"

Gore, J. M., Roberts, R., Ball, S. P., Montero, A., Goldberg, R. J., Dalen, J. E. Peak creatine kinase as a measure of effectiveness of thrombolytic therapy in acute myocardial infarction American Journal of Cardiology. 1987;59(15):1234-8. Abstract

Rao, A. K., Pratt, C., Berke, A., Jaffe, A., Ockene, I., Schreiber, T. L., Bell, W. R., Knatterud, G., Robertson, T. L., Terrin, M. L. Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase Journal of the American College of Cardiology. 1988;11(1):11-Jan. Abstract

Ong, L., Coromilas, J., Zimmerman, J. M., Green, S., Padmanabhan, V., Reiser, P., Bigger, J. T., Jr., Morrison, J. A physiologically based model of creatine kinase-MB release in reperfusion of acute myocardial infarction American Journal of Cardiology. 1989;64(1):5-Nov. Abstract

Lawler, C. M., Bovill, E. G., Stump, D. C., Collen, D. J., Mann, K. G., Tracy, R. P. Fibrin fragment D-dimer and fibrinogen B beta peptides in plasma as markers of clot lysis during thrombolytic therapy in acute myocardial infarction Blood. 1990;76(7):1341-8. Abstract

Flaker, G. C., Bartolozzi, J., Davis, V., McCabe, C., Cannon, C. P. Use of a standardized heparin nomogram to achieve therapeutic anticoagulation after thrombolytic therapy in myocardial infarction. TIMI 4 investigators. Thrombolysis in Myocardial Infarction Archives of internal medicine. 1994;154(13):1492-6. Abstract

Hall, C., Cannon, C. P., Forman, S., Braunwald, E. Prognostic value of N-terminal proatrial natriuretic factor plasma levels measured within the first 12 hours after myocardial infarction. Thrombolysis in Myocardial Infarction (TIMI) II Investigators Journal of the American College of Cardiology. 1995;26(6):1452-6. Abstract

Antman, E. M., Tanasijevic, M. J., Thompson, B., Schactman, M., McCabe, C. H., Cannon, C. P., Fischer, G. A., Fung, A. Y., Thompson, C., Wybenga, D., Braunwald, E. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes New England journal of medicine. 1996;335(18):1342-9. Abstract

Becker, R. C., Cannon, C. P., Bovill, E. G., Tracy, R. P., Thompson, B., Knatterud, G. L., Randall, A., Braunwald, B. Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial) American journal of cardiology. 1996;78(2):142-7. Abstract

Scharfstein, J. S., Abendschein, D. R., Eisenberg, P. R., George, D., Cannon, C. P., Becker, R. C., Sobel, B., Cupples, L. A., Braunwald, E., Loscalzo, J. Usefulness of fibrinogenolytic and procoagulant markers during thrombolytic therapy in predicting clinical outcomes in acute myocardial infarction. TIMI-5 Investigators. Thrombolysis in Myocardial Infarction American journal of cardiology. 1996;78(5):503-10. Abstract

Tanasijevic, M. J., Cannon, C. P., Wybenga, D. R., Fischer, G. A., Grudzien, C., Gibson, C. M., Winkelman, J. W., Antman, E. M., Braunwald, E. Myoglobin, creatine kinase MB, and cardiac troponin-I to assess reperfusion after thrombolysis for acute myocardial infarction: results from TIMI 10A American heart journal. 1997;134(4):622-30. Abstract

Antman, E. M., Sacks, D. B., Rifai, N., McCabe, C. H., Cannon, C. P., Braunwald, E. Time to positivity of a rapid bedside assay for cardiac-specific troponin T predicts prognosis in acute coronary syndromes: a Thrombolysis in Myocardial Infarction (TIMI) 11A substudy J Am Coll Cardiol. 1998;31(2):326-30. Abstract

Callas, P. W., Tracy, R. P., Bovill, E. G., Cannon, C., Thompson, B., Mann, K. G. The Association of Anticoagulant Protein Concentrations with Acute Myocardial Infarction in the Thromholysis in Myocardial Infarction Phase II (TIMI II) Trial Journal of thrombosis and thrombolysis. 1998;5(1):53-60. Abstract

Morrow, D. A., Rifai, N., Antman, E. M., Weiner, D. L., McCabe, C. H., Cannon, C. P., Braunwald, E. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction J Am Coll Cardiol. 1998;31(7):1460-5. Abstract

Gurfinkel, E. P., Scirica, B. M., Bozovich, G., Macchia, A., Manos, E., Mautner, B. Serum neopterin levels and the angiographic extent of coronary arterial narrowing in unstable angina pectoris and in non-Q-wave acute myocardial infarction Am J Cardiol. 1999;83(4):515-8. Abstract

Morrow, D. A., Antman, E. M., Tanasijevic, M., Rifai, N., de Lemos, J. A., McCabe, C. H., Cannon, C. P., Braunwald, E. Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy J Am Coll Cardiol. 2000;36(6):1812-7. Abstract

Morrow, D. A., Rifai, N., Antman, E. M., Weiner, D. L., McCabe, C. H., Cannon, C. P., Braunwald, E. Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy J Am Coll Cardiol. 2000;35(2):358-62. Abstract

Morrow, D. A., Rifai, N., Tanasijevic, M. J., Wybenga, D. R., de Lemos, J. A., Antman, E. M. Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: a Thrombolysis In Myocardial Infarction (TIMI) 11B Substudy Clin Chem. 2000;46(4):453-60. Abstract

de Lemos, J. A., Antman, E. M., Morrow, D. A., Llevadot, J., Giugliano, R. P., Coulter, S. A., Schuhwerk, K. C., Arslanian, S., McCabe, C. H., Gibson, C. M., Rifai, N. Heart-type fatty acid binding protein as a marker of reperfusion after thrombolytic therapy Clin Chim Acta. 2000;298(2-Jan):85-97. Abstract

Morrow, D. A., Cannon, C. P., Rifai, N., Frey, M. J., Vicari, R., Lakkis, N., Robertson, D. H., Hille, D. A., DeLucca, P. T., DiBattiste, P. M., Demopoulos, L. A., Weintraub, W. S., Braunwald, E. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial JAMA. 2001;286(19):2405-12. Abstract

Srinivas, V. S., Cannon, C. P., Gibson, C. M., Antman, E. M., Greenberg, M. A., Tanasijevic, M. J., Murphy, S., de Lemos, J. A., Sokol, S., Braunwald, E., Mueller, H. S. Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: a Thrombolysis in Myocardial Infarction 10B substudy Am Heart J. 2001;142(1):29-36. Abstract

Wang-Clow, F., Fox, N. L., Cannon, C. P., Gibson, C. M., Berioli, S., Bluhmki, E., Danays, T., Braunwald, E., Van De Werf, F., Stump, D. C. Determination of a weight-adjusted dose of TNK-tissue plasminogen activator Am Heart J. 2001;141(1):33-40. Abstract

de Lemos, J. A., Morrow, D. A., Bentley, J. H., Omland, T., Sabatine, M. S., McCabe, C. H., Hall, C., Cannon, C. P., Braunwald, E. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes N Engl J Med. 2001;345(14):1014-21. Abstract

Kleiman, N. S., Lakkis, N., Cannon, C. P., Murphy, S. A., DiBattiste, P. M., Demopoulos, L. A., Weintraub, W. S., Braunwald, E. Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non-ST-elevation acute coronary syndromes J Am Coll Cardiol. 2002;40(6):1044-50. Abstract

Omland, T., de Lemos, J. A., Morrow, D. A., Antman, E. M., Cannon, C. P., Hall, C., Braunwald, E. Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes Am J Cardiol. 2002;89(4):463-5.

Sabatine, M. S., Morrow, D. A., de Lemos, J. A., Gibson, C. M., Murphy, S. A., Rifai, N., McCabe, C., Antman, E. M., Cannon, C. P., Braunwald, E. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide Circulation. 2002;105(15):1760-3. Abstract

Wong, G. C., Morrow, D. A., Murphy, S., Kraimer, N., Pai, R., James, D., Robertson, D. H., Demopoulos, L. A., DiBattiste, P., Cannon, C. P., Gibson, C. M. Elevations in troponin T and I are associated with abnormal tissue level perfusion: a TACTICS-TIMI 18 substudy. Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction Circulation. 2002;106(2):202-7.

de Lemos, J. A., Morrow, D. A., Gibson, C. M., Murphy, S. A., Sabatine, M. S., Rifai, N., McCabe, C. H., Antman, E. M., Cannon, C. P., Braunwald, E. The prognostic value of serum myoglobin in patients with non-ST-segment elevation acute coronary syndromes. Results from the TIMI 11B and TACTICS-TIMI 18 studies J Am Coll Cardiol. 2002;40(2):238-44. Abstract

Christenson, R. H., Leino, E. V., Giugliano, R. P., Bahr, R. D. Usefulness of prodromal unstable angina pectoris in predicting better survival and smaller infarct size in acute myocardial infarction (The InTIME-II Prodromal Symptoms Substudy) Am J Cardiol. 2003;92(5):598-600. Abstract

Morrow, D. A., Rifai, N., Sabatine, M. S., Ayanian, S., Murphy, S. A., de Lemos, J. A., Braunwald, E., Cannon, C. P. Evaluation of the AccuTnI cardiac troponin I assay for risk assessment in acute coronary syndromes Clin Chem. 2003;49(8):1396-8.

Morrow, D. A., de Lemos, J. A., Sabatine, M. S., Murphy, S. A., Demopoulos, L. A., DiBattiste, P. M., McCabe, C. H., Gibson, C. M., Cannon, C. P., Braunwald, E. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18 J Am Coll Cardiol. 2003;41(8):1264-72.

Pinto, D. S., Lorenz, D. P., Murphy, S. A., Marble, S. J., DiBattiste, P. M., Demopoulos, L. A., Cannon, C. P., Gibson, C. M. Association of an activated clotting time < or =250 seconds with adverse event rates after percutaneous coronary intervention using tirofiban and heparin (a TACTICS-TIMI 18 substudy) Am J Cardiol. 2003;91(8):976-8, A4.

Varo, N., de Lemos, J. A., Libby, P., Morrow, D. A., Murphy, S. A., Nuzzo, R., Gibson, C. M., Cannon, C. P., Braunwald, E., Schonbeck, U. Soluble CD40L: risk prediction after acute coronary syndromes Circulation. 2003;108(9):1049-52. Abstract

de Lemos, J. A., Morrow, D. A., Sabatine, M. S., Murphy, S. A., Gibson, C. M., Antman, E. M., McCabe, C. H., Cannon, C. P., Braunwald, E. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes Circulation. 2003;107(5):690-5. Abstract

Mega, J. L., Morrow, D. A., De Lemos, J. A., Sabatine, M. S., Murphy, S. A., Rifai, N., Gibson, C. M., Antman, E. M., Braunwald, E. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy J Am Coll Cardiol. 2004;44(2):335-9. Abstract

Sabatine, M. S., Morrow, D. A., de Lemos, J. A., Omland, T., Desai, M. Y., Tanasijevic, M., Hall, C., McCabe, C. H., Braunwald, E. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia J Am Coll Cardiol. 2004;44(10):1988-95. Abstract

Sadanandan, S., Cannon, C. P., Chekuri, K., Murphy, S. A., Dibattiste, P. M., Morrow, D. A., de Lemos, J. A., Braunwald, E., Gibson, C. M. Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction J Am Coll Cardiol. 2004;44(3):564-8. Abstract

Shimpo, M., Morrow, D. A., Weinberg, E. O., Sabatine, M. S., Murphy, S. A., Antman, E. M., Lee, R. T. Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction Circulation. 2004;109(18):2186-90. Abstract

Wiviott, S. D., Cannon, C. P., Morrow, D. A., Murphy, S. A., Gibson, C. M., McCabe, C. H., Sabatine, M. S., Rifai, N., Giugliano, R. P., DiBattiste, P. M., Demopoulos, L. A., Antman, E. M., Braunwald, E. Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudy Circulation. 2004;109(5):580-6.

Dokainish, H., Pillai, M., Murphy, S. A., DiBattiste, P. M., Schweiger, M. J., Lotfi, A., Morrow, D. A., Cannon, C. P., Braunwald, E., Lakkis, N. Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: a TACTICS-TIMI-18 substudy J Am Coll Cardiol. 2005;45(1):19-24.

Moghbeli, N., Kirtane, A. J., Ray, K. K., Murphy, S. A., Gibson, C. M., Braunwald, E., Cannon, C. P. C-reactive protein and cardiovascular outcomes in smokers versus nonsmokers in non-ST-elevation acute coronary syndrome (from the TACTICS-TIMI 18 trial) Am J Cardiol. 2005;96(5):635-8.

Morrow, D. A., de Lemos, J. A., Blazing, M. A., Sabatine, M. S., Murphy, S. A., Jarolim, P., White, H. D., Fox, K. A., Califf, R. M., Braunwald, E. Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease JAMA. 2005;294(22):2866-71.

O'Donoghue, M., Chen, A., Baggish, A. L., Anwaruddin, S., Krauser, D. G., Tung, R., Januzzi, J. L. The effects of ejection fraction on N-terminal ProBNP and BNP levels in patients with acute CHF: analysis from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study J Card Fail. 2005;11(5 Suppl):S9-14. Abstract

Ohman, E. M., Van de Werf, F., Antman, E. M., Califf, R. M., de Lemos, J. A., Gibson, C. M., Oliverio, R. L., Harrelson, L., McCabe, C., DiBattiste, P., Braunwald, E. Tenecteplase and tirofiban in ST-segment elevation acute myocardial infarction: results of a randomized trial Am Heart J. 2005;150(1):79-88.

Ray, K. K., Cannon, C. P., Cairns, R., Morrow, D. A., Rifai, N., Kirtane, A. J., McCabe, C. H., Skene, A. M., Gibson, C. M., Ridker, P. M., Braunwald, E. Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial J Am Coll Cardiol. 2005;46(8):1417-24.

Ray, K. K., Morrow, D. A., Gibson, C. M., Murphy, S., Antman, E. M., Braunwald, E. Predictors of the rise in vWF after ST elevation myocardial infarction: implications for treatment strategies and clinical outcome: An ENTIRE-TIMI 23 substudy Eur Heart J. 2005;26(5):440-6.

Ridker, P. M., Cannon, C. P., Morrow, D., Rifai, N., Rose, L. M., McCabe, C. H., Pfeffer, M. A., Braunwald, E. C-reactive protein levels and outcomes after statin therapy N Engl J Med. 2005;352(1):20-8.

Ridker, P. M., Morrow, D. A., Rose, L. M., Rifai, N., Cannon, C. P., Braunwald, E. Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: an analysis of the PROVE-IT TIMI-22 trial J Am Coll Cardiol. 2005;45(10):1644-8.

Sabatine, M. S., Liu, E., Morrow, D. A., Heller, E., McCarroll, R., Wiegand, R., Berriz, G. F., Roth, F. P., Gerszten, R. E. Metabolomic identification of novel biomarkers of myocardial ischemia Circulation. 2005;112(25):3868-75. Abstract

Gibson, C. M., Karmpaliotis, D., Kosmidou, I., Murphy, S. A., Kirtane, A. J., Budiu, D., Ray, K. K., Herrmann, H. C., Lakkis, N., Kovach, R., French, W., Blankenship, J., Lui, H. H., Palabrica, T., Jennings, L. K., Cohen, D. J., Morrow, D. A. Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndrome Am J Cardiol. 2006;97(10):1473-7.

Gibson, C. M., Kirtane, A. J., Morrow, D. A., Palabrica, T. M., Murphy, S. A., Stone, P. H., Scirica, B. M., Jennings, L. K., Herrmann, H. C., Cohen, D. J., McCabe, C. H., Braunwald, E. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30) Am Heart J. 2006;152(4):756-61.

Januzzi, J. L., Jr., Newby, L. K., Murphy, S. A., Pieper, K., Antman, E. M., Morrow, D. A., Sabatine, M. S., Ohman, E. M., Cannon, C. P., Braunwald, E. Predicting a late positive serum troponin in initially troponin-negative patients with non-ST-elevation acute coronary syndrome: clinical predictors and validated risk score results from the TIMI IIIB and GUSTO IIA studies Am Heart J. 2006;151(2):360-6. Abstract

Mega, J. L., Morrow, D. A., Cannon, C. P., Murphy, S., Cairns, R., Ridker, P. M., Braunwald, E. Cholesterol, C-reactive protein, and cerebrovascular events following intensive and moderate statin therapy Journal of Thrombosis and Thrombolysis. 2006;22(1):71-76. Abstract

Morrow, D. A., de Lemos, J. A., Sabatine, M. S., Wiviott, S. D., Blazing, M. A., Shui, A., Rifai, N., Califf, R. M., Braunwald, E. Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial Circulation. 2006;114(4):281-8.

O'Donoghue, M., Morrow, D. A., Sabatine, M. S., Murphy, S. A., McCabe, C. H., Cannon, C. P., Braunwald, E. Lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction) trial Circulation. 2006;113(14):1745-52.

O'Donoghue, M., de Lemos, J. A., Morrow, D. A., Murphy, S. A., Buros, J. L., Cannon, C. P., Sabatine, M. S. Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes Circulation. 2006;114(6):550-7. Abstract

Ray, K. K., Morrow, D. A., Shui, A., Rifai, N., Cannon, C. P. Relation between soluble intercellular adhesion molecule-1, statin therapy, and long-term risk of clinical cardiovascular events in patients with previous acute coronary syndrome (from PROVE IT-TIMI 22) Am J Cardiol. 2006;98(7):861-5. Abstract

Sabatine, M. S., Morrow, D. A., McCabe, C. H., Antman, E. M., Gibson, C. M., Cannon, C. P. Combination of quantitative ST deviation and troponin elevation provides independent prognostic and therapeutic information in unstable angina and non-ST-elevation myocardial infarction Am Heart J. 2006;151(1):25-31.

Wallace, T. W., Abdullah, S. M., Drazner, M. H., Das, S. R., Khera, A., McGuire, D. K., Wians, F., Sabatine, M. S., Morrow, D. A., de Lemos, J. A. Prevalence and determinants of troponin T elevation in the general population Circulation. 2006;113(16):1958-65. Abstract

Bonaca, M. P., Wiviott, S. D., Sabatine, M. S., Buros, J., Murphy, S. A., Scirica, B. M., Rifai, N., Antman, E. M., Morrow, D. A. Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial) Am J Cardiol. 2007;99(3):344-8.

Januzzi, J. L., Jr., Peacock, W. F., Maisel, A. S., Chae, C. U., Jesse, R. L., Baggish, A. L., O'Donoghue, M., Sakhuja, R., Chen, A. A., van Kimmenade, R. R., Lewandrowski, K. B., Lloyd-Jones, D. M., Wu, A. H. Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study J Am Coll Cardiol. 2007;50(7):607-13. Abstract

Karmpaliotis, D., Kirtane, A. J., Ruisi, C. P., Polonsky, T., Malhotra, A., Talmor, D., Kosmidou, I., Jarolim, P., de Lemos, J. A., Sabatine, M. S., Gibson, C. M., Morrow, D. Diagnostic and prognostic utility of brain natriuretic Peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema Chest. 2007;131(4):964-71. Abstract

Morello, A., Lloyd-Jones, D. M., Chae, C. U., van Kimmenade, R. R., Chen, A. C., Baggish, A. L., O'Donoghue, M., Lee-Lewandrowski, E., Januzzi, J. L., Jr. Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study Am Heart J. 2007;153(1):90-7. Abstract

O'Donoghue, M., Kenney, P., Oestreicher, E., Anwaruddin, S., Baggish, A. L., Krauser, D. G., Chen, A., Tung, R., Cameron, R., Januzzi, J. L., Jr. Usefulness of aminoterminal pro-brain natriuretic peptide testing for the diagnostic and prognostic evaluation of dyspneic patients with diabetes mellitus seen in the emergency department (from the PRIDE Study) Am J Cardiol. 2007;100(9):1336-40. Abstract

Omland, T., Sabatine, M. S., Jablonski, K. A., Rice, M. M., Hsia, J., Wergeland, R., Landaas, S., Rouleau, J. L., Domanski, M. J., Hall, C., Pfeffer, M. A., Braunwald, E., Peace Investigators Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial J Am Coll Cardiol. 2007;50(3):205-14. Abstract

Ray, K. K., Cannon, C. P., Morrow, D. A., Kirtane, A. J., Buros, J., Rifai, N., McCabe, C. H., Gibson, C. M., Braunwald, E. Synergistic relationship between hyperglycaemia and inflammation with respect to clinical outcomes in non-ST-elevation acute coronary syndromes: analyses from OPUS-TIMI 16 and TACTICS-TIMI 18 Eur Heart J. 2007;28(7):806-13. Abstract

Ray, K. K., Morrow, D. A., Sabatine, M. S., Shui, A., Rifai, N., Cannon, C. P., Braunwald, E. Long-term prognostic value of neopterin: a novel marker of monocyte activation in patients with acute coronary syndrome Circulation. 2007;115(24):3071-8.

Sabatine, M. S., Morrow, D. A., Jablonski, K. A., Rice, M. M., Warnica, J. W., Domanski, M. J., Hsia, J., Gersh, B. J., Rifai, N., Ridker, P. M., Pfeffer, M. A., Braunwald, E., Peace Investigators Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease Circulation. 2007;115(12):1528-36. Abstract

Sabatine, M. S., Morrow, D. A., O'Donoghue, M., Jablonksi, K. A., Rice, M. M., Solomon, S., Rosenberg, Y., Domanski, M. J., Hsia, J. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease Arterioscler Thromb Vasc Biol. 2007;27(11):2463-9. Abstract

de Lemos, J. A., Morrow, D. A., Blazing, M. A., Jarolim, P., Wiviott, S. D., Sabatine, M. S., Califf, R. M., Braunwald, E. Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial J Am Coll Cardiol. 2007;50(22):2117-24. Abstract

Green, S. M., Martinez-Rumayor, A., Gregory, S. A., Baggish, A. L., O'Donoghue, M. L., Green, J. A., Lewandrowski, K. B., Januzzi, J. L., Jr. Clinical uncertainty, diagnostic accuracy, and outcomes in emergency department patients presenting with dyspnea Arch Intern Med. 2008;168(7):741-8. Abstract

Mega, J. L., Morrow, D. A., de Lemos, J. A., Mohanavelu, S., Cannon, C. P., Sabatine, M. S. Thrombus precursor protein and clinical outcomes in patients with acute coronary syndromes J Am Coll Cardiol. 2008;51(25):2422-9. Abstract

Morrow, D. A., Sabatine, M. S., Brennan, M. L., de Lemos, J. A., Murphy, S. A., Ruff, C. T., Rifai, N., Cannon, C. P., Hazen, S. L. Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18 Eur Heart J. 2008;29(9):1096-102.

Morrow, D. A., Wang, Y., Croce, K., Sakuma, M., Sabatine, M. S., Gao, H., Pradhan, A. D., Healy, A. M., Buros, J., McCabe, C. H., Libby, P., Cannon, C. P., Braunwald, E., Simon, D. I. Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial Am Heart J. 2008;155(1):49-55.

Olenchock, B. A., Wiviott, S. D., Murphy, S. A., Cannon, C. P., Rifai, N., Braunwald, E., Morrow, D. A. Lack of association between soluble CD40L and risk in a large cohort of patients with acute coronary syndrome in OPUS TIMI-16 J Thromb Thrombolysis. 2008;26(2):79-84. Abstract

Sabatine, M. S., Morrow, D. A., Higgins, L. J., MacGillivray, C., Guo, W., Bode, C., Rifai, N., Cannon, C. P., Gerszten, R. E., Lee, R. T. Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction Circulation. 2008;117(15):1936-44.

Keshishian, H., Addona, T., Burgess, M., Mani, D. R., Shi, X., Kuhn, E., Sabatine, M. S., Gerszten, R. E., Carr, S. A. Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution Mol Cell Proteomics. 2009;8(10):2339-49. Abstract

Kuhn, E., Addona, T., Keshishian, H., Burgess, M., Mani, D. R., Lee, R. T., Sabatine, M. S., Gerszten, R. E., Carr, S. A. Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry Clin Chem. 2009;55(6):1108-17. Abstract

Omland, T., de Lemos, J. A., Sabatine, M. S., Christophi, C. A., Rice, M. M., Jablonski, K. A., Tjora, S., Domanski, M. J., Gersh, B. J., Rouleau, J. L., Pfeffer, M. A., Braunwald, E., Prevention of Events with Angiotensin Converting Enzyme Inhibition Trial, Investigators A sensitive cardiac troponin T assay in stable coronary artery disease N Engl J Med. 2009;361(26):2538-47. Abstract

Ray, K. K., Cannon, C. P., Cairns, R., Morrow, D. A., Ridker, P. M., Braunwald, E. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22 Arteriosclerosis, thrombosis, and vascular biology. 2009;29(3):424-30. Abstract

Sabatine, M. S., Morrow, D. A., de Lemos, J. A., Jarolim, P., Braunwald, E. Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35 European heart journal. 2009;30(2):162-9. Abstract

Scirica, B. M., Cannon, C. P., Sabatine, M. S., Jarolim, P., Sloane, S., Rifai, N., Braunwald, E., Morrow, D. A. Concentrations of C-reactive protein and B-type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascular death Clin Chem. 2009;55(2):265-73.

Wilson, S. R., Sabatine, M. S., Braunwald, E., Sloan, S., Murphy, S. A., Morrow, D. A. Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 Trial American heart journal. 2009;158(3):386-91. Abstract

Bonaca, M., Scirica, B., Sabatine, M., Dalby, A., Spinar, J., Murphy, S. A., Jarolim, P., Braunwald, E., Morrow, D. A. Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I J Am Coll Cardiol. 2010;55(19):2118-24. Abstract

Bonaca, Marc P., Kudinova, Anastacia, Kakkar, Rahul, Scirica, Benjamin S., Sabatine, Marc S., Murphy, Sabina A., Braunwald, Eugene, Lee, Richard T., Morrow, David A. ST2 and the Risk of CV Death or Heart Failure in Patients with Non-ST elevation Acute Coronary Syndromes (NSTE-ACS): Observations from MERLIN-TIMI 36 Circulation. 2010;122(21):NA.

Bonaca, Marc P., Scirica, Bejamin M., Sabatine, Marc S., Jarolim, Petr, Murphy, Sabina A., Chamberlin, Janna S., Rhodes, Daniel W., Southwick, Paula C., Braunwald, Eugene, Morrow, David A. Metalloproteinase PAPP-A and Outcomes in Patients with ACS: Observations from the MERLIN-TIMI 36 Trial Circulation. 2010;122(21):NA.

Husted, S., Storey, R. F., Harrington, R. A., Emanuelsson, H., Cannon, C. P. Changes in inflammatory biomarkers in patients treated with ticagrelor or clopidogrel Clin Cardiol. 2010;33(4):206-12. Abstract

Lewis, G. D., Farrell, L., Wood, M. J., Martinovic, M., Arany, Z., Rowe, G. C., Souza, A., Cheng, S., McCabe, E. L., Yang, E., Shi, X., Deo, R., Roth, F. P., Asnani, A., Rhee, E. P., Systrom, D. M., Semigran, M. J., Vasan, R. S., Carr, S. A., Wang, T. J., Sabatine, M. S., Clish, C. B., Gerszten, R. E. Metabolic signatures of exercise in human plasma Sci Transl Med. 2010;2(33):33ra37. Abstract

Morrow, D. A., Scirica, B. M., Sabatine, M. S., de Lemos, J. A., Murphy, S. A., Jarolim, P., Theroux, P., Bode, C., Braunwald, E. B-type natriuretic peptide and the effect of ranolazine in patients with non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary-Thrombolysis In Myocardial Infarction 36) trial Journal of the American College of Cardiology. 2010;55(12):1189-96. Abstract

O'Donoghue, M., Braunwald, E. Natriuretic peptides in heart failure: should therapy be guided by BNP levels? Nat Rev Cardiol. 2010;7(1):13-20. Abstract

Ray, K. K., Nazer, B., Cairns, R., Michael Gibson, C., Cannon, C. P. Association between percutaneous coronary intervention and long-term C-reactive protein levels in patients with acute coronary syndromes J Thromb Thrombolysis. 2010;30(1):3-Oct. Abstract

Scirica, B. M., Morrow, D. A., Bode, C., Ruzyllo, W., Ruda, M., Oude Ophuis, A. J., Lopez-Sendon, J., Swedberg, K., Ogorek, M., Rifai, N., Lukashevich, V., Maboudian, M., Cannon, C. P., McCabe, C. H., Braunwald, E. Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 Trial European heart journal. 2010;31(16):1993-2005. Abstract

Sherwood, M. W., Morrow, D. A., Scirica, B. M., Jiang, S. T., Bode, C., Rifai, N., Gerszten, R. E., Gibson, C. M., Cannon, C. P., Braunwald, E., Sabatine, M. S. Early dynamic risk stratification with baseline troponin levels and 90-minute ST-segment resolution to predict 30-day cardiovascular mortality in ST-segment elevation myocardial infarction: Analysis from CLopidogrel as Adjunctive ReperfusIon TherapY (CLARITY) - Thrombolysis in Myocardial Infarction (TIMI) 28 American Heart Journal. 2010;159(6):964-U3. Abstract

Syed, Zeeshan, Scirica, Benjamin M., Mohanavelu, Satishkumar, Morrow, David A., Stultz, Collin M., Guttag, John Association of Heart Rate Turbulence, Deceleration Capacity and Morphologic Variability with Sudden Cardiac Death Following Non-ST-Elevation Acute Coronary Syndrome: Results from the MERLIN-TIMI 36 Trial Circulation. 2010;122(21):NA.

Bonaca, M. P., Morrow, D. A., Braunwald, E., Cannon, C. P., Jiang, S., Breher, S., Sabatine, M. S., Kempf, T., Wallentin, L., Wollert, K. C. Growth differentiation factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome: observations from PROVE IT-TIMI 22 Arteriosclerosis, thrombosis, and vascular biology. 2011;31(1):203-10. Abstract

Bonaca, M. P., Ruff, C. T., Grandin, E. W., Murphy, S. A., Jarolim, P., Conrad, M. J., Vora, A., Sabatine, M. S., Braunwald, E., Morrow, D. A. Evaluation of the Diagnostic Performance of an Investigational Ultra-Sensitive Assay for CARDIAC TROPONIN I Journal of the American College of Cardiology. 2011;57(14):E1018-E1018.

Desai, N. R., Morrow, D. A., Murphy, S. A., Gerszten, R. E., Cannon, C. P., Sabatine, M. S. Evaluation of Multiple Biomarkers of Cardiomyocyte Stress or Injury to Predict Cardiovascular Death or CHF in STEMI: Findings from CLARITY-TIMI 28 Circulation. 2011;124(21):NA.

Nazer, B., Ray, K. K., Sloan, S., Scirica, B., Morrow, D. A., Cannon, C. P., Braunwald, E. Prognostic utility of neopterin and risk of heart failure hospitalization after an acute coronary syndrome European heart journal. 2011;32(11):1390-7. Abstract

O'Donoghue, M. L., Mallat, Z., Morrow, D. A., Benessiano, J., Sloan, S., Omland, T., Solomon, S. D., Braunwald, E., Tedgui, A., Sabatine, M. S. Prognostic utility of secretory phospholipase A(2) in patients with stable coronary artery disease Clinical chemistry. 2011;57(9):1311-7. Abstract

Ruff, C. T., Morrow, D. A., Jarolim, P., Ren, F., Contant, C. F., Kaur, A., Curtis, S. P., Laine, L., Cannon, C. P., Brune, K. Evaluation of NT-proBNP and high sensitivity C-reactive protein for predicting cardiovascular risk in patients with arthritis taking longterm nonsteroidal antiinflammatory drugs J Rheumatol. 2011;38(6):1071-8. Abstract

Scirica, B. M., Sabatine, M. S., Jarolim, P., Murphy, S. A., de Lemos, J. L., Braunwald, E., Morrow, D. A. Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial European heart journal. 2011;32(6):697-705. Abstract

Syed, Z., Stultz, C. M., Scirica, B. M., Guttag, J. V. Computationally generated cardiac biomarkers for risk stratification after acute coronary syndrome Sci Transl Med. 2011;3(102):102ra95. Abstract

Turer, A. T., Addo, T. A., Martin, J. L., Sabatine, M. S., Lewis, G. D., Gerszten, R. E., Keeley, E. C., Cigarroa, J. E., Lange, R. A., Hillis, L. D., de Lemos, J. A. Myocardial ischemia induced by rapid atrial pacing causes troponin T release detectable by a highly sensitive assay: insights from a coronary sinus sampling study J Am Coll Cardiol. 2011;57(24):2398-405. Abstract

Udell, J. A., Morrow, D. A., Contant, C. F., Brunel, P. C., Prescott, M. F., Braunwald, E., Scirica, B. M., Avant Garde-Timi Investigators Inhibition of Renin-Angiotensin System (RAS) Reduces the Rise in Plasma Aldosterone Levels After Acute Coronary Syndromes in Patients with Preserved Left Ventricular Function: Insight From AVANT GARDE-TIMI 43 Trial Circulation. 2011;124(21):NA.

Wilson, S. R., Sabatine, M. S., Wiviott, S. D., Ray, K. K., De Lemos, J. A., Zhou, S., Rifai, N., Cannon, C. P., Morrow, D. A., Timi Study Group Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: observations from the Pravastatin Or atorVastatin Evaluation and Infection Trial-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Am Heart J. 2011;161(6):1147-55 e1. Abstract

Wiviott, S. D., Flather, M. D., O'Donoghue, M. L., Goto, S., Fitzgerald, D. J., Cura, F., Aylward, P., Guetta, V., Dudek, D., Contant, C. F., Angiolillo, D. J., Bhatt, D. L., Lancelot-Cad Investigators Randomized trial of atopaxar in the treatment of patients with coronary artery disease: the lessons from antagonizing the cellular effect of Thrombin-Coronary Artery Disease Trial Circulation. 2011;123(17):1854-63. Abstract

Bonaca, M. P., Scirica, B. M., Sabatine, M. S., Jarolim, P., Murphy, S. A., Chamberlin, J. S., Rhodes, D. W., Southwick, P. C., Braunwald, E., Morrow, D. A. Prospective evaluation of pregnancy-associated plasma protein-a and outcomes in patients with acute coronary syndromes J Am Coll Cardiol. 2012;60(4):332-8. Abstract

Braunwald, E. Creating controversy where none exists: the important role of C-reactive protein in the CARE, AFCAPS/TexCAPS, PROVE IT, REVERSAL, A to Z, JUPITER, HEART PROTECTION, and ASCOT trials European heart journal. 2012;33(4):430-2.

Bui, A. H., Bonaca, M. P., Sabatine, M. S., Ray, K. K., Rifai, N., Cannon, C. P., Morrow, D. A. Elevated concentration of placental growth factor (PlGF) and long term risk in patients with acute coronary syndrome in the PROVE IT-TIMI 22 trial J Thromb Thrombolysis. 2012;34(2):222-8. Abstract

Chin, C. T., Wang, T. Y., Li, S., Wiviott, S. D., deLemos, J. A., Kontos, M. C., Peterson, E. D., Roe, M. T. Comparison of the prognostic value of peak creatine kinase-MB and troponin levels among patients with acute myocardial infarction: a report from the Acute Coronary Treatment and Intervention Outcomes Network Registry-get with the guidelines Clin Cardiol. 2012;35(7):424-9. Abstract

Grandin, E. W., Jarolim, P., Murphy, S. A., Ritterova, L., Cannon, C. P., Braunwald, E., Morrow, D. A. Galectin-3 and the development of heart failure after acute coronary syndrome: pilot experience from PROVE IT-TIMI 22 Clinical chemistry. 2012;58(1):267-73. Abstract

Kohli, P., Bonaca, M. P., Kakkar, R., Kudinova, A. Y., Scirica, B. M., Sabatine, M. S., Murphy, S. A., Braunwald, E., Lee, R. T., Morrow, D. A. Role of ST2 in non-ST-elevation acute coronary syndrome in the MERLIN-TIMI 36 trial Clinical chemistry. 2012;58(1):257-66. Abstract

Morrow, D. A., O'Donoghue, M. L. Galectin-3 in cardiovascular disease: a possible window into early myocardial fibrosis J Am Coll Cardiol. 2012;60(14):1257-8.

O'Donoghue, M. L., Bhatt, D. L., Flather, M. D., Goto, S., Angiolillo, D. J., Goodman, S. G., Zeymer, U., Aylward, P. E., Montalescot, G., Ziecina, R., Kobayashi, H., Ren, F., Wiviott, S. D. Atopaxar and its effects on markers of platelet activation and inflammation: results from the LANCELOT CAD program J Thromb Thrombolysis. 2012;34(1):36-43. Abstract

O'Malley, Ryan G, Morrow, David A, Bonaca, Marc P, Jarolim, Petr, Scirica, Benjamin M, Murphy, Sabina A, Conrad, Michael J, Cannon, Christopher P, Braunwald, Eugene, Sabatine, Marc S Abstract 11559: Determination of Cardiac Troponin with a Single-Molecule High-Sensitivity Assay and Outcomes in Patients with Stable Coronary Artery Disease: Analysis from PROVE IT-TIMI 22 Circulation. 2012;126(21 Supplement):A11559.

O'Malley, Ryan G., Bonaca, Marc, Sabatine, Marc, Scirica, Benjamin, Jarolim, Petr, Conrad, Michael, Murphy, Sabina, Braunwald, Eugene, Morrow, David PROGNOSTIC PERFORMANCE OF A SINGLE-MOLECULE HIGH-SENSITIVITY CARDIAC TROPONIN ASSAY AFTER NON-ST ELEVATION ACUTE CORONARY SYNDROME: ANALYSIS FROM MERLIN-TIMI 36 Journal of the American College of Cardiology. 2012;59(13):E402-E402.

Roysland, R., Bonaca, M. P., Omland, T., Sabatine, M., Murphy, S. A., Scirica, B. M., Bjerre, M., Flyvbjerg, A., Braunwald, E., Morrow, D. A. Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes Heart. 2012;98(10):786-91. Abstract

Steen, Dylan L, Cannon, Christopher P, Lele, Suhas, Rajapurkar, Mohan, Mukhopadhyay, Banibrata, Scirica, Benjamin M, Morrow, David A Abstract 18754: Prognostic Evaluation of Catalytic Iron in Patients with Acute Coronary Syndromes: Observations from OPUS-TIMI 16 Circulation. 2012;126(21 Supplement):A18754.

Vora, A. N., Bonaca, M. P., Ruff, C. T., Jarolim, P., Murphy, S., Croce, K., Sabatine, M. S., Simon, D. I., Morrow, D. A. Diagnostic evaluation of the MRP-8/14 for the emergency assessment of chest pain J Thromb Thrombolysis. 2012;34(2):229-34. Abstract

Bohula May, E. A., Bonaca, M. P., Jarolim, P., Antman, E. M., Braunwald, E., Giugliano, R. P., Newby, L. K., Sabatine, M. S., Morrow, D. A. Prognostic Performance of a High-Sensitivity Cardiac Troponin I Assay in Patients with Non-ST-Elevation Acute Coronary Syndrome Clin Chem. 2013;NA(NA):NA. Abstract

Bohula May, E. A., Scirica, B., Bonaca, M., Murphy, S., Braunwald, E. B., Morrow, D., Brigham and Women's Hospital Prognostic Value of High-Sensitivity CRP for Cardiovascular Outcomes in TRA 2P - TIMI 50 Journal of the American College of Cardiology. 2013;61(10):A287.

Bonaca MP, Ruff CT, Kosowsky J, Conrad MJ, Murphy SA, Sabatine MS, Jarolim P, Morrow DA. Evaluation of the diagnostic performance of current and next-generation assays for cardiac troponin I in the BWH-TIMI ED Chest Pain Study. Eur Heart J Acute Cardiovasc Care. 2013;2:195-202. Abstract

Buyukkaya, E., Poyraz, F., Karakas, M. F., Kurt, M., Akcay, A. B., Akpinar, I., Motor, S., Turak, O., Ozturk, O. H., Sen, N., Akpek, M., Kaya, M. G., Gibson, C. M. Usefulness of Monocyte Chemoattractant Protein-1 to Predict No-Reflow and Three-Year Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention Am J Cardiol. 2013;NA(NA):NA. Abstract

Celik, T., Kaya, M. G., Akpek, M., Yarlioglues, M., Sarli, B., Topsakal, R., Gibson, C. M. Does Serum Bilirubin Level on Admission Predict TIMI Flow Grade and In-Hospital MACE in Patients With STEMI Undergoing Primary PCI Angiology. 2013;NA(NA):NA. Abstract

Geller, B. J., Mega, J. L., Morrow, D. A., Guo, J., Hoffman, E. B., Gibson, C. M., Ruff, C. T. Autoantibodies to phosphorylcholine and cardiovascular outcomes in patients with acute coronary syndromes in the ATLAS ACS-TIMI 46 trial J Thromb Thrombolysis. 2013;NA(NA):NA. Abstract

Grinstein, J., Bonaca, M., Sabatine, M., Jarolim, P., Conrad, M. J., Braunwald, E. B., Giugliano, R. P., Newby, L. K., Morrow, D. A., Timi Study Group, Prognostic Implications of Low-Level Cardiac Troponin Elevation Using the High-Sensitivity Assay for Cardiac Troponin T: Results from EARLY ACS & SEPIA-TIMI 42 Journal of the American College of Cardiology. 2013;61(10):A27.

Holmes, M. V., Simon, T., Exeter, H. J., Folkersen, L., Asselbergs, F. W., Guardiola, M., Cooper, J. A., Palmen, J., Hubacek, J. A., Carruthers, K. F., Horne, B. D., Brunisholz, K. D., Mega, J. L., van Iperen, E. P., Li, M., Leusink, M., Trompet, S., Verschuren, J. J., Hovingh, G. K., Dehghan, A., Nelson, C. P., Kotti, S., Danchin, N., Scholz, M., Haase, C. L., Rothenbacher, D., Swerdlow, D. I., Kuchenbaecker, K. B., Staines-Urias, E., Goel, A., Hooft, F. V., Gertow, K., de Faire, U., Panayiotou, A. G., Tremoli, E., Baldassarre, D., Veglia, F., Holdt, L. M., Beutner, F., Gansevoort, R. T., Navis, G. J., Leach, I. M., Breitling, L. P., Brenner, H., Dallmeier, D., Franco-Cereceda, A., Boer, J., Stephens, J. W., Hofker, M. H., Tedgui, A., Hofman, A., Uitterlinden, A. G., Adamkova, V., Pitha, J., Onland-Moret, N. C., Cramer, M. J., Nathoe, H. M., Spiering, W., Klungel, O. H., Kumari, M., Whincup, P. H., Morrow, D. A., Braund, P. S., Hall, A. S., Olsson, A. G., Doevendans, P. A., Trip, M. D., Tobin, M. D., Hamsten, A., Watkins, H., Koenig, W., Nicolaides, A. N., Teupser, D., Day, I. N., Carlquist, J. F., Gaunt, T. R., Ford, I., Sattar, N., Tsimikas, S., Schwartz, G. G., Lawlor, D. A., Morris, R. W., Sandhu, M. S., Poledne, R., Maitland-van der Zee, A. H., Khaw, K. T., Keating, B. J., van der Harst, P., Price, J. F., Mehta, S. R., Yusuf, S., Witteman, J. C., Franco, O. H., Jukema, J. W., de Knijff, P., Tybjaerg-Hansen, A., Rader, D. J., Farrall, M., Samani, J., Kivimaki, M., Fox, K. A., Humphries, S. E., Anderson, J. L., Boekholdt, S. M., Palmer, T. M., Eriksson, P., Pare, G., Hingorani, A. D., Sabatine, M. S., Mallat, Z., Casas, J. P., Talmud, P. J. Secretory Phospholipase A2-IIA and Cardiovascular Disease: a Mendelian randomization study J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Hsich, E. M., Grau-Sepulveda, M. V., Hernandez, A. F., Eapen, Z. J., Xian, Y., Schwamm, L. H., Bhatt, D. L., Fonarow, G. C. Relationship between sex, ejection fraction, and B-type natriuretic peptide levels in patients hospitalized with heart failure and associations with inhospital outcomes: Findings from the Get With The Guideline-Heart Failure Registry Am Heart J. 2013;166(6):1063-1071 e3. Abstract

Morrow, D. A., Bonaca, M. P. Real-world application of "delta" troponin: diagnostic and prognostic implications J Am Coll Cardiol. 2013;62(14):1239-41.

Nazer, B., Ray, K. K., Murphy, S. A., Gibson, C. M., Cannon, C. P. Urinary albumin concentration and long-term cardiovascular risk in acute coronary syndrome patients: a PROVE IT-TIMI 22 substudy J Thromb Thrombolysis. 2013;36(3):233-9. Abstract

O'Donoghue, M., Morrow, D. A., Tsimikas, S., Sloan, S., Ren, A. F., Hoffman, E. B., Desai, N. P., Solomon, S. D., Domanski, M., Arai, K., Chiuve, S. E., Cannon, C. P., Sacks, F. M., Sabatine, M. S. Lipoprotein (a) For Risk Assessment in Patients with Established Coronary Artery Disease J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

O'Malley, R. G., Sabatine, M. S., Bonaca, M. P., Murphy, S., Jarolim, P., Conrad, M. J., Cannon, C. P., Braunwald, E. B., Morrow, D. A. Prognostic Performance of Srial High Sensitivity Cardiac Troponin Determination in Stable Ischemic Heart Disease: Analysis from PROVE IT-TIMI 22 Journal of the American College of Cardiology. 2013;61(10):A283.

Omland, T., Pfeffer, M. A., Solomon, S. D., de Lemos, J. A., Rosjo, H., Saltyte Benth, J., Maggioni, A., Domanski, M. J., Rouleau, J. L., Sabatine, M. S., Braunwald, E., Peace Investigators Prognostic Value of Cardiac Troponin I Measured With a Highly Sensitive Assay in Patients With Stable Coronary Artery Disease J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Ruff CT, Bonaca MP, Kosowsky JM, Conrad MJ, Murphy SA, Jarolim P, Donahoe SM, O'Donoghue ML, Morrow DA. Evaluation of the diagnostic performance of heart-type fatty acid binding protein in the BWH-TIMI ED chest pain study. J Thromb Thrombolysis. 2013;36:361-367. Abstract

Ruff CT, Bonaca MP, Kosowsky JM, Conrad MJ, Murphy SA, Jarolim P, Donahoe SM, O'Donoghue ML, Morrow DA. Erratum to: Evaluation of the diagnostic performance of heart-type fatty acid binding protein in the BWH-TIMI ED chest pain study. J Thromb Thrombolysis. 2013;36:368.

Ruff, C. T., Bonaca, M. P., Kosowsky, J. M., Conrad, M. J., Murphy, S. A., Jarolim, P., Donahoe, S. M., O'Donoghue, M. L., Morrow, D. A. Evaluation of the diagnostic performance of heart-type fatty acid binding protein in the BWH-TIMI ED chest pain study J Thromb Thrombolysis. 2013;NA(NA):NA. Abstract

Scirica, B. M., Kadakia, M. B., de Lemos, J. A., Roe, M. T., Morrow, D. A., Li, S., Wiviott, S. D., Kontos, M. C., on behalf of the National Cardiovascular Data, Registry Association between Natriuretic Peptides and Mortality among Patients Admitted with Myocardial Infarction: A Report from the ACTION Registry(R)-GWTG Clin Chem. 2013;NA(NA):NA. Abstract

Smith, S. W., Diercks, D. B., Nagurney, J. T., Hollander, J. E., Miller, C. D., Schrock, J. W., Singer, A. J., Apple, F. S., McCullough, P. A., Ruff, C. T., Sesma, A., Jr., Peacock, W. F. Central versus local adjudication of myocardial infarction in a cardiac biomarker trial Am Heart J. 2013;165(3):273-279 e1. Abstract

Steen, Dylan L., Cannon, Christopher P., Lele, Suhas S., Rajapurkar, Mohan M., Mukhopadhyay, Banibrata, Scirica, Benjamin M., Murphy, Sabina A., Morrow, David A. Prognostic Evaluation of Catalytic Iron in Patients With Acute Coronary Syndromes Clinical Cardiology. 2013;NA(NA):n/a-n/a.

Tricoci, P., Leonardi, S., White, J., White, H. D., Armstrong, P. W., Montalescot, G., Giugliano, R. P., Gibson, C. M., Van de Werf, F., Califf, R. M., Harrington, R. A., Braunwald, E., Mahaffey, K. W., Newby, L. K. Cardiac Troponin after Percutaneous Coronary Intervention and 1-Year Mortality in NSTE ACS Using Systematic Evaluation of Biomarker Trends J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Udell, J. A., Morrow, D. A., Braunwald, E., Swedberg, K., Bode, C., Rifai, N., Brunel, P. C., Prescott, M. F., Ren, F., Hoffman, E. B., Scirica, B. M. Inhibition of the Renin-Angiotensin System Reduces the Rise in Serum Aldosterone in Acute Coronary Syndrome Patients with Preserved Left Ventricular Function: Observations from the AVANT GARDE-TIMI 43 Trial Clin Chem. 2013;NA(NA):NA. Abstract

Udell, Jacob A, Morrow, David A, Jarolim, Petr, Sloan, Sarah, Hoffman, Elaine B, O'Donnell, Thomas F, Vora, Amit V, Omland, Torbjorn, Solomon, Scott D, Pfeffer, Marc A, Braunwald, Eugene, Sabatine, Marc S Abstract 10291: Fibroblast Growth Factor (FGF)-23, Cardiovascular Prognosis, and Benefit of Angiotensin-Converting Enzyme Inhibition in Patients With Stable Coronary Artery Disease Circulation. 2013;128(22 Supplement):A10291.

Wallentin L, Lindholm D, Siegbahn A, Wernroth L, Becker RC, Cannon CP, Cornel JH, Himmelmann A, Giannitsis E, Harrington RA, Held C, Husted S, Katus HA, Mahaffey KW, Steg PG, Storey RF, James SK; PLATO study group. Biomarkers in Relation to the Effects of Ticagrelor Compared with Clopidogrel in Non-ST-Elevation Acute Coronary Syndrome Patients Managed with or without In-Hospital Revascularization: A Substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) Trial. Circulation. 2013;129:293-303. Abstract

Kato, Eri Toda, Bonaca, Marc, Morrow, David, Jarolim, Petr, Sloan, Sarah, Solomon, Scott, Braunwald, Eugene, Sabatine, Marc GROWTH DIFFERENTIATION FACTOR-15 (GDF-15) AND THE RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE Journal of the American College of Cardiology. 2014;63(12, Supplement):A1525.

May, Erin Ann Bohula, Bonaca, Marc, Scirica, Benjamin, Kuder, Julia, Murphy, Sabina, Jarolim, Petr, Sabatine, Marc, Morrow, David GROWTH DIFFERENTIATION FACTOR-15 LEVEL PREDICTS RECURRENT CARDIOVASCULAR EVENTS IN PATIENTS WITH AN ACUTE CORONARY SYNDROME IN MERLIN-TIMI 36 Journal of the American College of Cardiology. 2014;63(12, Supplement):A20.

O'Malley, R. G., Bonaca, M. P., Scirica, B. M., Murphy, S. A., Jarolim, P., Sabatine, M. S., Braunwald, E., Morrow, D. A. Prognostic Performance of Multiple Biomarkers in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: Analysis From the MERLIN-TIMI 36 Trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36) J Am Coll Cardiol. 2014;63(16):1644-53. Abstract

Scirica, Benjamin, Bhatt, Deepak, Braunwald, Eugene, Raz, Itamar, Steg, Philippe, Davidson, Jaime, Cavender, Matthew, Hirshberg, Boaz, Umez-Eronini, Amarachi, Im, Kelly, Jarolim, Petr, Morrow, David Prognostic Implications of Simultaneous Biomarker Assessments in Patients with Type 2 Diabetes Mellitus: Observations from the SAVOR-TIMI 53 TRIAL Journal of the American College of Cardiology. 2014;63(12, Supplement):A1550.

Udell, J. A., Morrow, D. A., Jarolim, P., Sloan, S., Hoffman, E. B., O'Donnell, T. F., Vora, A. N., Omland, T., Solomon, S. D., Pfeffer, M. A., Braunwald, E., Sabatine, M. S. Fibroblast Growth Factor-23, Cardiovascular Prognosis, and Benefit of Angiotensin-Converting Enzyme Inhibition in Stable Ischemic Heart Disease J Am Coll Cardiol. 2014;NA(NA):NA. Abstract